Sponsor:
Merck Sharp & Dohme LLC
Code:
NCT06428409
Conditions
Colorectal Cancer
Pancreatic Ductal Adenocarcinoma
Biliary Tract Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab tirumotecan
Fluorouracil (5-FU)
Leucovorin (LV) or levoleucovorin
Rescue medication
Supportive care measures
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-07. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2026-01-22.